BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34256790)

  • 1. The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based study.
    Sandø AD; Fougner R; Grønbech JE; Bringeland EA
    World J Surg Oncol; 2021 Jul; 19(1):212. PubMed ID: 34256790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?
    Sandø AD; Grønbech JE; Bringeland EA
    Acta Oncol; 2023 Dec; 62(12):1846-1853. PubMed ID: 37903117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer.
    Gertsen EC; de Jongh C; Brenkman HJF; Mertens AC; Broeders IAMJ; Los M; Boerma D; Ten Bokkel Huinink D; van Leeuwen L; Wessels FJ; van Hillegersberg R; Ruurda JP
    Eur J Surg Oncol; 2020 Jul; 46(7):1247-1253. PubMed ID: 32349895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study.
    Yoshikawa T; Tanabe K; Nishikawa K; Ito Y; Matsui T; Kimura Y; Hasegawa S; Aoyama T; Hayashi T; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S385-9. PubMed ID: 24595801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric Cancer.
    Sandø AD; Fougner R; Røyset ES; Dai HY; Grønbech JE; Bringeland EA
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
    Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
    Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic ultrasound in restaging and predicting pathological response for advanced gastric cancer patients after neoadjuvant chemotherapy.
    Guo T; Yao F; Yang AM; Li XY; Zhong DR; Wu DS; Wu X; Lu XH
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e28-32. PubMed ID: 23279745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy versus none for resectable gastric cancer.
    Wu AW; Xu GW; Wang HY; Ji JF; Tang JL
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005047. PubMed ID: 17443566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Neoadjuvant chemotherapy versus none for resectable gastric cancer.
    Wu AW; Xu GW; Wang HY; Ji JF; Tang JL
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005047. PubMed ID: 17943834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 12. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
    Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
    Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Accuracy comparision of abdominal enhanced CT and endoscopic ultrasound in the staging of gastric cancer after neoadjuvant chemotherapy: a post hoc analysis of a randomized clinical trial].
    Wang YK; Shan F; Ying XJ; Zhang Y; Xiao QY; Tang L; Wu Q; Li ZY; Ji JF
    Zhonghua Wai Ke Za Zhi; 2020 Aug; 58(8):614-618. PubMed ID: 32727193
    [No Abstract]   [Full Text] [Related]  

  • 14. Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
    Park SR; Lee JS; Kim CG; Kim HK; Kook MC; Kim YW; Ryu KW; Lee JH; Bae JM; Choi IJ
    Cancer; 2008 Jun; 112(11):2368-76. PubMed ID: 18404697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A patient with advanced gastric cancer who obtained downstaging and underwent radical surgery by neoadjuvant chemotherapy].
    Kawahara M; Nashimoto A; Yabusaki H; Takii Y; Tsuchiya Y; Tanaka O; Sasaki J
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):609-12. PubMed ID: 10791005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
    Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
    Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.
    Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S
    Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy.
    Xu Q; Sun Z; Li X; Ye C; Zhou C; Zhang L; Lu G
    Eur Radiol; 2021 Nov; 31(11):8765-8774. PubMed ID: 33909133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic overview of chemotherapy effects in gastric cancer.
    Janunger KG; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):309-26. PubMed ID: 11441938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment Outcomes of Advanced Gastric Cancer after Neoadjuvant Chemotherapy with S-1 and Cisplatin].
    Funaki H; Fujii Y; Miura S; Fujita J; Morioka E; Kaida D; Ohnishi T; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1421-1423. PubMed ID: 28133010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.